dc.creatorGrimaldi Jr., Gabriel
dc.date2017-06-06T13:59:25Z
dc.date2017-06-06T13:59:25Z
dc.date2008
dc.date.accessioned2023-09-26T22:23:54Z
dc.date.available2023-09-26T22:23:54Z
dc.identifierGRIMALDI JR., Gabriel. The utility of rhesus monkey (Macaca mulatta) and other non-human primate models for preclinical testing of Leishmania candidate vaccines - a review. Mem. Inst. Oswaldo Cruz, v.103, n.7, p.629-644. 2008.
dc.identifier0074-0276
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/19317
dc.identifier10.1590/S0074-02762008000700002
dc.identifier1678-8060
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8878739
dc.descriptionLeishmaniasis causes significant morbidity and mortality, constituting an important global health problem for which there are few effective drugs. Given the urgent need to identify a safe and effective Leishmania vaccine to help prevent the two million new cases of human leishmaniasis worldwide each year, all reasonable efforts to achieve this goal should be made. This includes the use of animal models that are as close to leishmanial infection in humans as is practical and feasible. Old world monkey species (macaques, baboons, mandrills etc.) have the closest evolutionary relatedness to humans among the approachable animal models. The Asian rhesus macaques (Macaca mulatta) are quite susceptible to leishmanial infection, develop a human-like disease, exhibit antibodies to Leishmania and parasite-specific T-cell mediated immune responses both in vivo and in vitro, and can be protected effectively by vaccination. Results from macaque vaccine studies could also prove useful in guiding the design of human vaccine trials. This review summarizes our current knowledge on this topic and proposes potential approaches that may result in the more effective use of the macaque model to maximize its potential to help the development of an effective vaccine for human leishmaniasis.
dc.formatapplication/pdf
dc.languageeng
dc.publisherFundação Oswaldo Cruz. Instituto Oswaldo Cruz
dc.rightsopen access
dc.subjectPrimatas não-humanos
dc.subjectDesenvolvimento da vacina Leishmania
dc.subjectLeishmaniose experimental
dc.subjectexperimental leishmaniasis
dc.subjectLeishmania vaccine development
dc.subjectnon-human primates
dc.titleThe utility of rhesus monkey (Macaca mulatta) and other non-human primate models for preclinical testing of Leishmania candidate vaccines - a review
dc.typeArticle


Este ítem pertenece a la siguiente institución